Publications by authors named "Marissa Betts"

Article Synopsis
  • Novel therapies are changing how endometrial cancer (EC) is treated, with a systematic review assessing first-line treatments for advanced or recurrent cases.
  • The review included 108 records from 57 trials, showing varied results with median progression-free survival between 1.9 to 18.8 months and overall survival from 6.9 to 41 months.
  • Concerns about adverse events from conventional treatments suggest that while efficacy is suboptimal, the promising safety and effectiveness of immunotherapies could significantly alter EC management moving forward.
View Article and Find Full Text PDF
Article Synopsis
  • Biologic treatments have shown promise in achieving complete skin clearance for moderate to severe plaque psoriasis, with bimekizumab demonstrating superior efficacy compared to other treatments like secukinumab, adalimumab, and ustekinumab in clinical trials.
  • A systematic literature review and network meta-analysis evaluated 19 randomized controlled trials to compare the efficacy and safety of bimekizumab against other biologic therapies over one year, focusing on improvements in the Psoriasis Area and Severity Index (PASI).
  • The results indicated that bimekizumab 320 mg given every 4 weeks, then every 8 weeks, was more effective in achieving complete skin clearance compared to most other biologics, particularly highlighting the efficacy
View Article and Find Full Text PDF

The Cambrian explosion, one of the most consequential biological revolutions in Earth history, occurred in two phases separated by the Sinsk event, the first major extinction of the Phanerozoic. Trilobite fossil data show that Series 2 strata in the Ross Orogen, Antarctica, and Delamerian Orogen, Australia, record nearly identical and synchronous tectono-sedimentary shifts marking the Sinsk event. These resulted from an abrupt pulse of contractional supracrustal deformation on both continents during the trilobite Zone.

View Article and Find Full Text PDF

Patients with cancer have an increased risk of venous thromboembolism (VTE). Comparing tumor-specific VTE risk is complicated by factors such as surgery, disease stage, and chemotherapy. Network meta-analysis (NMA) using cancer types as network nodes enabled us to estimate VTE rates by leveraging comparisons across cancer types while adjusting for baseline VTE risk in individual studies.

View Article and Find Full Text PDF

The evolutionary mechanism behind the early Cambrian animal skeletonization was a complex and multifaceted process involving environmental, ecological, and biological factors. Predation pressure, oxygenation, and seawater chemistry change have frequently been proposed as the main drivers of this biological innovation, yet the selection pressures from microorganisms have been largely overlooked. Here we present evidence that calcareous shells of the earliest mollusks from the basal Cambrian (Fortunian Age, ca.

View Article and Find Full Text PDF

Introduction: The psychological burden of type 1 diabetes mellitus (T1DM) is considerable. The condition affects the daily lives of adults living with T1DM (ALWT1DM) in many ways. International guidelines highlight the importance of providing psychological support to ALWT1DM to improve health outcomes and well-being.

View Article and Find Full Text PDF

Objective: Tests capable of accurate prediction of spontaneous preterm birth (sPTB) are crucial to inform clinical decisions to prevent neonatal deaths and reduce the risk of morbidity in surviving infants. A systematic literature review and meta-analysis were performed to assess the utility of the quantitative fetal fibronectin (fFN) test to predict sPTB at different test concentration thresholds.

Methods: Literature searches were conducted in MEDLINE, Embase, and the Cochrane Library in May 2022.

View Article and Find Full Text PDF
Article Synopsis
  • * Eight different methods were evaluated for handling related publications when analyzing the annualized relapse rate (ARR) of therapies for multiple sclerosis using Bayesian NMA.
  • * Results indicated that selecting one main study from related publications yielded consistent ARR ratios, while including all studies led to changes in results, suggesting a need for a structured approach to publication selection in NMAs of RWE.
View Article and Find Full Text PDF

Background: Dopamine antagonists are the main pharmacological options to treat gastroparesis. The aim of this study was to conduct a systematic literature review (SLR) to evaluate the profile of adverse events (AEs) of dopamine antagonists used in the treatment of children and adults with gastroparesis.

Methods: We searched EMBASE and MEDLINE up to March 25, 2021, for relevant clinical trials and observational studies.

View Article and Find Full Text PDF

The Precambrian-Cambrian interval saw the first appearance of disparate modern metazoan phyla equipped with a wide array of mineralized exo- and endo-skeletons. However, the current knowledge of this remarkable metazoan skeletonization bio-event and its environmental interactions is limited because uncertainties have persisted in determining the mineralogy, microstructure, and hierarchical complexity of these earliest animal skeletons. This study characterizes in detail a previously poorly understood fibrous microstructure-the lamello-fibrillar (LF) nacre-in early Cambrian mollusk and hyolith shells and compares it with shell microstructures in modern counterparts (coleoid cuttlebones and serpulid tubes).

View Article and Find Full Text PDF
Article Synopsis
  • Biologic disease-modifying anti-rheumatic drugs (bDMARDs) like certolizumab pegol (CZP) are effective for treating non-radiographic spondyloarthritis (nr-axSpA), but direct comparisons among different bDMARDs are limited.
  • A systematic literature review and indirect treatment comparison were conducted to evaluate how CZP compares to other bDMARDs in terms of efficacy for patients with nr-axSpA who did not respond to traditional anti-inflammatory drugs.
  • Results indicated that CZP had significant advantages in achieving better disease response markers compared to etanercept, ixekizumab, and secukinumab, particularly noticeable in patients exhibiting objective signs of inflammation.
View Article and Find Full Text PDF
Article Synopsis
  • Biologic treatments like bimekizumab, which inhibits IL-17A and IL-17F, are being increasingly used to manage moderate to severe plaque psoriasis (PSO), with this study evaluating its short-term efficacy compared to other biologics.
  • A systematic review identified 86 randomized controlled trials involving over 34,000 patients, utilizing a sophisticated network meta-analysis to assess treatment effectiveness at various improvements measured by the Psoriasis Area and Severity Index (PASI) over 10-16 weeks.
  • Results showed that bimekizumab outperformed other treatments significantly for achieving substantial improvements (PASI 90 and PASI 100), establishing it as one of the most effective options for PSO in the short
View Article and Find Full Text PDF

To compare real-world effectiveness/safety of non-vitamin K antagonist oral anticoagulants and vitamin K antagonists among patients with non-valvular atrial fibrillation. A systematic review of electronic databases yielded 7661 citations published from January 2013 to January 2020. Fifty-five studies were included in Bayesian network meta-analyses of hazard ratios.

View Article and Find Full Text PDF

Background: Eribulin mesylate (ERI; Halaven®) is a microtubule inhibitor approved in the United States for metastatic breast cancer patients with at least two prior chemotherapy regimens for metastatic breast cancer, and in the European Union in locally advanced breast cancer or metastatic breast cancer patients who progressed after at least one chemotherapy for advanced disease. This network meta-analysis compared the efficacy and safety of ERI versus other chemotherapies in this setting.

Methods: Systematic searches conducted in MEDLINE, Embase, and the Cochrane Central Register of Clinical Trials identified randomized controlled trials of locally advanced breast cancer/metastatic breast cancer chemotherapies in second- or later-line settings.

View Article and Find Full Text PDF

Hyoliths (hyolithids and orthothecids) were one of the most successful early biomineralizing lophotrochozoans and were a key component of the Cambrian evolutionary fauna. However, the morphology, skeletogenesis and anatomy of earliest members of this enigmatic clade, as well as its relationship with other lophotrochozoan phyla remain contentious. Here, we present a new orthothecid, gen.

View Article and Find Full Text PDF

Objective: Identify the most recent utility value estimates for cardiovascular disease (CVD) via systematic literature review (SLR) and explore trends in utility elicitation methods in the last 6 years.

Methods: This SLR was updated on January 25, 2018, and identified studies reporting utilities for myocardial infarction (MI), stroke, angina, peripheral artery disease (PAD), and any-cause revascularization by searching Embase, PubMed, Health Technology Assessment Database, and grey literature.

Results: A total of 375 studies reported CVD utilities (pre-2013 vs post-2013: MI, 38 vs 32; stroke, 86 vs 113; stable angina, 8 vs 9; undefined/unstable angina, 23 vs 8; PAD, 29 vs 13; revascularization, 54 vs 40).

View Article and Find Full Text PDF

Purpose: β-Thalassemia is an inherited blood disorder characterized by reduced or no production of adult hemoglobin. Systematic identification of the burden of β-thalassemia with contemporary treatments is lacking in published literature. Thus, a gap exists in understanding the baseline burden on which to assess future treatments.

View Article and Find Full Text PDF

Objectives: To identify risk equations for cardiovascular diseases (CVDs) in primary and secondary prevention settings that are used or recommended by health technology assessment (HTA) organizations and in clinical guidelines (CGs).

Methods: A targeted literature review was conducted using a two-stage search strategy. First, HTA reviews of manufacturers' drug submissions, reports from established HTA organizations (Europe, Canada, and Australia), and CGs from countries with and without HTA organizations, including the United States, were identified.

View Article and Find Full Text PDF

Background: Hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis) is a progressive, life-threatening disease. Until recently, tafamidis was the only approved pharmacotherapy. Patisiran significantly improved polyneuropathy and quality of life (QoL) in the phase III APOLLO trial.

View Article and Find Full Text PDF